NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Cardiovascular Assessment and Treatment During COPD Exacerbation to Improve Diagnosis and Outcomes

Active Not RecruitingNA

Sponsor: Tel-Aviv Sourasky Medical Center

Conditions: COPD (Chronic Obstructive Pulmonary Disease), Cardiovascular Diseases

Interventions: Cardiologist evaluation, Pulmonologist evaluation

Countries: Israel

This is a research study involving patients hospitalized for COPD flare-ups. Patients will be randomly assigned to two groups: one group will only see a pulmonologist (lung doctor), and the other group will also be seen by a cardiologist (heart doctor) during their hospital stay. Both groups will fill out a questionnaire, and the pulmonologist will review their lung disease, adjust their treatment, and recommend follow-up care. The cardiologist will also assess the second group for heart diseases (like high cholesterol, diabetes, heart disease, high blood pressure, or heart failure) and start or adjust heart treatment if needed. Both groups will be followed up by phone 1, 3, 6 and 12 months later to check for changes in treatment, new heart problems, COPD flare-ups, or death.

Eligibility overview

Sex: ALL

Age: 18 Years to 75 Years

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* Documented COPD (based on lung function tests, symptoms and relevant treatment).
* Aged 18-75 years.
* Mentally competent to understand and follow medical recommendations.

Exclusion Criteria:

* Under 18 years of age.
* Unable to provide consent.
* Unstable concurrent disease.

Locations (1)

Tel Aviv, Israel